CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 349313-349571 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2663","span":{"begin":0,"end":258},"obj":"Sentence"},{"id":"T29790","span":{"begin":0,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study compared mortality in hospitalised patients who had received amoxicillin/macrolide (narrow spectrum, NS) with those who had received either co-amoxiclav/macrolide or a second/ third-generation cephalosporin/macrolide (broad spectrum, BS Objective:"}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T60","span":{"begin":0,"end":258},"obj":"Sentence"}],"text":"This study compared mortality in hospitalised patients who had received amoxicillin/macrolide (narrow spectrum, NS) with those who had received either co-amoxiclav/macrolide or a second/ third-generation cephalosporin/macrolide (broad spectrum, BS Objective:"}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1198","span":{"begin":112,"end":114},"obj":"Disease"},{"id":"T1199","span":{"begin":245,"end":247},"obj":"Disease"},{"id":"T12872","span":{"begin":112,"end":114},"obj":"Disease"},{"id":"T5649","span":{"begin":245,"end":247},"obj":"Disease"}],"attributes":[{"id":"A1198","pred":"mondo_id","subj":"T1198","obj":"http://purl.obolibrary.org/obo/MONDO_0009735"},{"id":"A1199","pred":"mondo_id","subj":"T1199","obj":"http://purl.obolibrary.org/obo/MONDO_0008876"},{"id":"A68120","pred":"mondo_id","subj":"T12872","obj":"http://purl.obolibrary.org/obo/MONDO_0009735"},{"id":"A24794","pred":"mondo_id","subj":"T5649","obj":"http://purl.obolibrary.org/obo/MONDO_0008876"}],"text":"This study compared mortality in hospitalised patients who had received amoxicillin/macrolide (narrow spectrum, NS) with those who had received either co-amoxiclav/macrolide or a second/ third-generation cephalosporin/macrolide (broad spectrum, BS Objective:"}